Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

GELITA Celebrates New Collagen Peptide Production Facility

CapsCanada
 
K2VITAL®

In the presence of officials from the State of Iowa, Woodbury County and Sioux City, GELITA USA along with GELITA’s global management board were celebrating the recent commissioning of a new collagen peptide facility at its campus near Sioux City, IA. GELITA marked the facility start-up with an open-house event to offer a preview and extend thanks to those government officials, contractors, suppliers and other business associates who partnered with GELITA during the construction process.

Globally, GELITA’s collagen peptides have experienced double digit market growth, according to the company. As the pioneer in collagen peptide research and production, this production expansion further secures GELITA’s position as market leader and allows for greater flexibility and future growth, the company stated. This production is directly derived from raw materials using a gentle enzymatic process to create tailor-made and optimized collagen peptides, which are key ingredients in foods and nutritional supplements for their protein content and physiological benefits. Further, GELITA’s collagen peptides are supported by a robust body of scientific research making GELITA the “go-to” collagen expert in the food and health and nutrition sectors.

Pablo Silber, GELITA USA general manager, noted, “The 30,000-plus-square-foot facility will—when operational at full capacity—expand the site’s production capacity by about 30 percent and will feature state-of-the-art technology and equipment for the production of globally demanded high quality, scientifically researched collagen peptides.” Silber added that GELITA’s decision to expand is based upon U.S. and global market trends and insights where collagen demand is projected for future and substantial growth.

Two years ago, GELITA’s management board reached the decision to construct this facility at GELITA’s Sioux City location due to excellent infrastructure and workforce. GELITA expects this facility to be fully operational in the upcoming months further expanding GELITA’s global supply of collagen peptides from its broad and diverse product portfolio. As the U.S. is a major market for these collagen peptides, this U.S.-based expansion will now position the product much closer to the U.S. customer base.

In the U.S., GELITA’s operations are coordinated from the North American headquarters in Sergeant Bluff, IA, where the company currently operates four separate production facilities, making it the nation’s largest single-site producer of collagen proteins. This Sergeant Bluff production capability is complimented by operations based in Calumet City, IL. Globally headquartered in Eberbach, Germany, GELITA operates more than 20 production sites around the world on five continents: North America, South America, Europe, Asia and Australia.

For more information, visit www.gelita.com/en.

CapsCanada
 
K2VITAL®